United BioSource LLC (UBC), a leading provider of evidence development solutions to the biopharmaceutical industry, today announced the appointment of Anthony Luttenberger as its new Chief Commercial Officer.
Anthony brings extensive executive leadership and strategic sales experience, spanning the pharmaceutical product life cycle including late-stage drug development, clinical trials, and product commercialization, to UBC. He is skilled at leveraging actionable insights derived from real-world data, real-world evidence, outcomes research, robust analytics, and informatics to inform innovative program design. Anthony will play a crucial role in supporting UBC’s market position through the delivery of a comprehensive commercial strategy.
